Genomics Boom Boosts Sales of Research Tools
Genomics and Medicine: transformative therapies are coming but diagnostic breakthroughs will lead the way Ten years after the start of the Human Genome Project we have learned a lot about the links between genetics and disease but few direct cures have emerged. The biotech Company Human Genome...
Rayno Life Science Portfolio Update: Finally a Rally Day
Any momentum in biotech stocks from ASCO have been eclipsed by bearish, volatile trends overall. There were some nice moves up today with the Rayno Life Science Portfolio was up 2.67% and all bio ETF's did well: FBT up 3%,XBI up 3.48%, and IBB up 3.11%. Among the big movers in the Rayno...
ASCO: Little Help for Biotech Stocks
Two Big Winners in Bristol Myers Squibb and Celgene The American Society of Oncology Meeting is normally good times for biotech as scientific and clinical developments propel stocks. This year the personalized medicine theme with potential breakthroughs in targeted therapy for cancer is...
Cubist (CBST) Pharmaceuticals Up 3% on Heavy Volume
In a nasty market where many indices are down 2.5% or more Cubist bucks the trend up 3% apparently on a Cowen and Co. upgrade from Neutral to Outperform.As of midday trading with a Volume of 2.8M shares the stock is at $22.25 up from $21.5 yesterday. The stock is up this year reaching a high of...
Genetic Testing Gets a Boost From Medco(MHS)
Diagnostic Medicine is on the Forefront Genetic tests and the new field of pharmacogenomics is getting marketing support from an unlikely source-Pharmacy Benefit Managers (PBM's). Medco (MHS), a $60B revenue PBM ($26B Market Cap)with over 65M members has been developing a strategy for...